Melatonin in rapid eye movement sleep behavior disorder: Why does it work?

Sleep Medicine

Volumn 14, Issue 8, 2013, Pages 705-706

  Kunz, Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; MELATONIN;

ALZHEIMER DISEASE; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CLINICAL OBSERVATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HORMONE SYNTHESIS; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MUSCLE ATONIA; PARASOMNIA; PATIENT COMPLIANCE; PINEAL BODY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; RESTLESSNESS; SLEEP PATTERN; SLEEP QUALITY; SLEEP STAGE; SLEEP TIME; SLEEP WAKING CYCLE; TREATMENT OUTCOME;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHRONOBIOLOGY PHENOMENA; HUMANS; MELATONIN; REM SLEEP BEHAVIOR DISORDER;

EID: 84881550009     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.05.004     Document Type: Editorial

References (20)

1. Boeve B.F. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann NY Acad Sci 2010, 1184:15-54.
2. Wyatt J.K., Dijk D.J., Ritz-de Cecco A., Ronda J.M., Czeisler C.A. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 2006, 29:609-618.
3. Dawson D., Armstrong S.M. Chronobiotics-drugs that shift rhythms. Pharmacol Ther 1996, 69:15-36.
4. Wirz-Justice A., Armstrong S.M. Melatonin: nature's soporific?. J Sleep Res 1996, 5:137-141.
5. Roth T., Richardson G. Commentary: is melatonin administration an effective hypnotic?. J Biol Rhythms 1997, 12:666-669.
6. Kunz D. Chronobiotic protocol and circadian sleep propensity index: new tools for clinical routine and research on melatonin and sleep. Pharmacopsychiatry 2004, 37:139-146.
7. Kunz D., Mahlberg R. Melatonin: a chronobiotic that not only shifts rhythms. Melatonin: biological basis of its function in health and diseases 2004, 1-11. Biosciences, Landes. S.R. Pandi-Perumal, D.P. Cardinali (Eds.).
8. Kunz D., Bes F. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology 1997, 36:211-214.
9. Bes F.W., Jobert M., Müller L.C., Schulz H. The diurnal distribution of sleep propensity: experimental data about the interaction of the propensities for slow-wave sleep and REM sleep. J Sleep Res 1996, 5:90-98.
10. Dijk D.J., Czeisler C.A. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 1995, 15:3526-3538.
11. Wurts S.W., Seidel W.F., Dement W.C., Edgar D.M. Effects of suprachiasmatic nucleus lesions on REM sleep continuity. Sleep Res 1997, 26:758.
12. van den Heuvel C.J., Reid K.J., Dawson D. Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. Physiol Behav 1997, 61:795-802.
13. Mahlberg R., Haedel S., Heidenreich J., Schmitz S., Kunz D. Degree of pineal calcification (DOC) is associated with polysomnographic sleep measures. Sleep Med 2009, 10:439-445.
14. Kunz D., Mahlberg R., Muller C., Tilmann A., Bes F. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials. J Clin Endocrinol Metab 2004, 89:128-134.
15. Schenck C.H., Montplaisir J.Y., Frauscher B., Hogl B., Gagnon J.F., Postuma R., et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med 2013, 14:795-806.
16. Kunz D., Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 2010, 19:591-596.
17. Turek F.W., Dugovic C. RBD - an emerging clue to neurodegenerative disorders. Sleep 2005, 28:920-921.
18. Schenck C.H., Boeve B.F., Mahowald M.W. Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16year update on a previously reported series. Sleep Med 2013, 14:744-748.
19. Kunz D., Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999, 14:507-511.
20. Mahlberg R., Kunz D., Sutej I., Kühl K.P., Hellweg R. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer's disease: an open-label pilot study using actigraphy. J Clin Psychopharmacol 2004, 24:456-459.